LONDON, Nov 21 (Reuters) - Eye company Optos said growing demand for a new flagship product in a number of markets would underpin steady growth next year, after it posted an 19 percent drop in annual ...

Please provide your email address to receive an email when new articles are posted on . Toku’s BioAge software will be integrated into ultra-widefield retinal imaging devices from Optos. BioAge can ...

Shares in Optos gain 3.4 percent as the medical products firm receives U.S. Food and Drug Administration clearance to market its Daytona Device, the company's next-generation ultra-wide field retinal ...

These full-year results for ophthalmology specialist Optos (OPTS) helped repair the damage done to sentiment from a profit miss at the half-year stage. Helped by its new range of Daytona retinal ...

Signs emerged in March that the retinal imaging specialist Optos (OPOSF.PK) might be approaching a pothole in the road. The 90% drop in profits announced by the company this morning, however, was ...

Retinal imaging firm Optos is planning to expand its product range and international reach after reporting a surge in revenues. The Fife-based company said overall revenues climbed 37% to $196.4m ...

Nikon will acquire the Optos Group for £259.3 million ($400 million) as part of its long-term plan to expand into the medical sector. Last June, the long-suffering camera giant restructured and ...